Clinical Trial

Comparative Study Between the Effect of Dexmedetomidine ,Midazolam or Bupivacaine Packing During FESS on Surgical Field Visualization

Study acronym: FESS (Function
Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this interventional study is to compare the nasal packing with dexmedetomidine .midazolam or bupivacaine on surgical field visualization during FESS . Study groups : Group I (Group C): (control group) Patients in this group will receive only 5 ml of intranasal saline. Group II (Group D): Patients in this group will receive only intranasal Dexmedetomidine (1 mcg/kg) made up to 5 ml in normal saline. Group III (Group M): Patients in this group will receive only intranasal midazolam (0.2 mg/kg) made up to 5 ml in normal saline. Group IV (Group B): Patients in this group will receive only intranasal bupivacaine (0.5% solution) 5 ml.
Trial Details
NCT Number NCT07013955
Lead Sponsor Minia University
Conditions Surgical Hemostasis
Enrollment 144 participants
Start Date 2025-04-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-10